All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
October 2023: Lurasidone added to the formulary after commissioning policies accepted in Devon
News
October 2023: Lurasidone added to the formulary after commissioning policies accepted in Devon
Lurasidone 18.5mg, 37mg and 74mg tablets have been added to the formulary as an amber (specialist input) option for the management of schizophrenia in line with the Devon commissioning policy (see below).
- Click here for the formulary entry.
The routine commissioning of lurasidone is accepted in Devon for the management of schizophrenia in adults only in line with specified criteria.
- Click here for the commissioning policy.
The routine commissioning of lurasidone is accepted in Devon for the management of schizophrenia in children and adolescents (aged 13 years and above) only in line with specified criteria.
- Click here for the commissioning policy.
